GB619572A - Improvements in and relating to the production of an antibiotic - Google Patents

Improvements in and relating to the production of an antibiotic

Info

Publication number
GB619572A
GB619572A GB3761946A GB3761946A GB619572A GB 619572 A GB619572 A GB 619572A GB 3761946 A GB3761946 A GB 3761946A GB 3761946 A GB3761946 A GB 3761946A GB 619572 A GB619572 A GB 619572A
Authority
GB
United Kingdom
Prior art keywords
antibiotic
per cent
sulphate
fluid
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3761946A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEOFFREY CLOUGH AINSWORTH
JAMES CAMERON MACSWEEN
Wellcome Foundation Ltd
Original Assignee
GEOFFREY CLOUGH AINSWORTH
JAMES CAMERON MACSWEEN
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEOFFREY CLOUGH AINSWORTH, JAMES CAMERON MACSWEEN, Wellcome Foundation Ltd filed Critical GEOFFREY CLOUGH AINSWORTH
Priority to GB3761946A priority Critical patent/GB619572A/en
Publication of GB619572A publication Critical patent/GB619572A/en
Expired legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

An antibiotic is obtained by making a culture of the species of bacteria known as Bacillus aerosporus Greer or B. polymyxa (Prazmowski) Migula, removing the bacterial cells from the metabolism product (e.g. by filtration or centrifuging), adsorbing the antibiotic on activated charcoal under neutral conditions (pH 6-8) and eluting it with a solvent therefor. The culturing of the bacillus (of which strains shown by biological assay to give a high yield of the antibiotic are preferably selected) is effected aerobically (in shallow layers or in deeper vessels with artificial aeration) on the usual culture media, the best results being obtained with an aqueous medium (pH about 7.4) containing about 10 per cent by volume of nutrient broth with the addition of small amounts (e.g. 3 per cent and 0.6 per cent respectively) of glucose and diammonium hydrogen phosphate and a trace (e.g. 0.002 per cent) of manganese sulphate. The adsorption of the antibiotic on charcoal is preferably preceded by a preliminary treatment at pH 2.0-2.5 with an activated charcoal which under such conditions adsorbs colouring matter and impurities but not the antibiotic. Elution, preferably preceded by washing with dilute hydrochloric acid (pH 2.0-2.5) or water, or both, may be effected with aqueous acetone (about 40 per cent concentration) acidified (pH about 2.5) with sulphuric acid, and the sulphate of the antibiotic may be precipitated from the eluate by adding acetone until the concentration thereof is about 75 per cent and cooling (to about 4 DEG C.), and may be purified by dissolving in water, neutralizing (pH 7) with alkali, filtering and freeze drying. Alternatively the eluate is adjusted to pH 3, the acetone distilled off under reduced pressure, the antibiotic (sulphate) again adsorbed on charcoal from the aqueous solution and eluted as before and the eluate neutralized with calcium carbonate, filtered and freeze dried; or, after evaporation of the acetone, picric acid may be added to precipitate the picrate of the antibiotic. The sulphate may be converted by treatment with hydrochloric acid or calcium chloride, to the hydrochloride, which may be further purified by dissolving it in methanol and reprecipitating it with ether. Alternatively the hydrochloride may be obtained directly by washing the charcoal on which the antibiotic is adsorbed with neutral ethanol (twice), eluting with dry methanolic hydrochloric acid (approximately decinormal) and precipitating with ether. Purification of the sulphate, hydrochloride or picrate may also be effected by conversion to the helianthate by dissolving in aqueous methanol and adding a saturated solution of methyl orange, preferably such amount that about 80 per cent of the antibiotic activity is associated with the precipitate. The bacterial cells after separation from the metabolism fluid may be subjected to autolysis, e.g. by suspension in sterile saline solution (preferably with the addition of 1 per cent of toluene) and incubation at about 37 DEG C. for about 48 hours, and the resulting supernatant fluid added to or worked up in the same way as the metabolism fluid.ALSO:In the production of an antibiotic, a culture of the species of bacteria known as Bacillus aerosporous Greer or B. polymyxa (Praymowski) Migula is made on the usual culture media, preferably an aqueous medium (pH about 7.4) containing about 10 per cent by volume of nutrient broth with the addition of small amounts (e.g. 3 per cent and 0.6 per cent respectively) of glucose and diammonium hydrogen phosphate and a race (e.g. 0.002 per cent) of manganese sulphate. The culturing (for which strains of the bacillus shown by biological assay to give a high yield of antibiotic are preferably selected) is effected aerobically, e.g. at 22-28 DEG C., in shallow layers (for 3-8 days) or in deeper vessels with artificial aeration for 20 - 24 hours). The metabolism fluid is separated from the bacteria (e.g. by filtration or centrifuging, if desired with the addition of 0.4 per cent of chloroform as preservative) and is worked up to recover the antibiotic, whilst the residual bacteria may be subjected to autolysis, e.g. by suspension in sterile saline solution (preferably with the addition of 1 per cent of toluene) and incubation at about 37 DEG C. for about 48 hours, and the resulting supernatant fluid may be added to or used in the same way as the metabolism fluid.
GB3761946A 1946-12-21 1946-12-21 Improvements in and relating to the production of an antibiotic Expired GB619572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3761946A GB619572A (en) 1946-12-21 1946-12-21 Improvements in and relating to the production of an antibiotic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3761946A GB619572A (en) 1946-12-21 1946-12-21 Improvements in and relating to the production of an antibiotic

Publications (1)

Publication Number Publication Date
GB619572A true GB619572A (en) 1949-03-10

Family

ID=10397780

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3761946A Expired GB619572A (en) 1946-12-21 1946-12-21 Improvements in and relating to the production of an antibiotic

Country Status (1)

Country Link
GB (1) GB619572A (en)

Similar Documents

Publication Publication Date Title
Nomoto et al. A proteolytic enzyme of Streptomyces griseus: I. Purification of a protease of Streptomyces griseus
SU469266A3 (en) The method of obtaining 7-amino-deacetoxycephalosporanic acid
US3733320A (en) Antibiotic purification processes
US2599950A (en) Method of preparing polymyxin
US3334022A (en) Neocarzinostatin produced by streptomyces carzinost aticus var. neocarzinostaticus
US3767799A (en) Antibiotic proticin
GB619572A (en) Improvements in and relating to the production of an antibiotic
US2505053A (en) Method for recovering grisein
US2695261A (en) Production of polymyxins a, b, and e
GB1163270A (en) A new Antibiotic Enduracidin and a process for the production thereof
US3089816A (en) Lemacidine and process for its manufacture
US3042588A (en) Process for producing cobalaminpeptide complexes
JPS5920359B2 (en) Production method of polylysine
US2940966A (en) Glucoside of 2-amino-4-hydroxy-6-(1', 2'-dihydroxypropyl)-pteridine
JPS5831196B2 (en) SF-1771 Bushitsuno Seizouhou
JPS6120268B2 (en)
US2781340A (en) Extraction of coenzyme a from microbiological materials
US3627882A (en) Antibiotic dermadin and a process for producing the same
JPS62158492A (en) Production of oganomicin e
US3565988A (en) Antibiotic
JPS5819679B2 (en) New antibiotics and their production methods
US3261751A (en) Process of producing hamycin antibiotic and product produced
KR830000618B1 (en) Preparation method of new antibiotic SF-2050B
JPS62210996A (en) Production of antibiotic substance emimycin
US3657418A (en) Antibiotic histidomycin